SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension.
Le Ribeuz H, Masson B, Capuano V, Dutheil M, Gooroochurn H, Boët A, Ghigna MR, De Montpreville V, Girerd B, Lambert M, Mercier O, Chung WK, Humbert M, Montani D, Antigny F.
Le Ribeuz H, et al. Among authors: de montpreville v.
Am J Respir Cell Mol Biol. 2022 May;66(5):539-554. doi: 10.1165/rcmb.2021-0180OC.
Am J Respir Cell Mol Biol. 2022.
PMID: 35175177